SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Chemical Name: (8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diyl diacetate
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Smiles: CC(O[C@@]1(C#C)CC[C@@]2([H])[C@]3([H])C=CC4=CC(OC(C)=O)CC[C@]4([H])[C@@]3([H])CC[C@]12C)=O
Norethindrone Acetate Impurity 4 is chemically (8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diyl diacetate. Norethindrone Acetate Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Norethindrone Acetate Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Norethindrone Acetate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Method development and validation of norethindrone acetate assay and its related impurities in API and pharmaceutical formulation with ortogonal detector technques
By Satish, J.; Radhakrishnanand, P.; Babu, K. Surendra
From International Journal of Pharmacy and Pharmaceutical Sciences (2017), 9(12), 110-118
Norethindrone acetate (NA) and ethynyl estradiol (EE) related oxidative transformation products in stability samples of formulated drug product: synthesis of authentic references
By Ekhato, I. Victor; Hurley, Tim; Lovdahl, Michael; Revitte, T. J.; Guo, Luyi; Huang, Yun; Clipper, Scott; Colson, Charles
From Steroids (2002), 67(3,4), 165-174